Pharmetheus Platforms
Harness the power of data integration to support decision-making and achieve predictions beyond observations. Explore the different Pharmetheus Platforms established for this purpose.
Our platforms
We draw from a variety of platforms’ ways of working and solutions to assist your team in planning and conducting efficient analyses of collected data. Here are the Pharmetheus Platforms that can be leveraged.
A quantitative framework to support and inform development program strategies and decisions.
Physiologically-based pharmacokinetics (PBPK) and physiologically-based biopharmaceutics modeling (PBBM) leverage accumulated knowledge to inform mechanistic analyses and achieve predictions beyond direct observations. These models integrate physiological and drug-specific parameters to optimize drug development, refine dosing strategies, and enhance risk assessment.
To analyze both drug concentration (pharmacokinetic) and effects (pharmacodynamic) data using a population modeling approach. The adopted quantitative approach enables efficient integration of longitudinal information across subjects and across study protocols.
When the clinical or in-vivo data isn’t enough to support your drug development decisions, Quantitative Systems Pharmacology (QSP) integrates data and knowledge about the drug, target and disease mechanisms that underpin the therapeutic hypothesis.
What we do
We believe quantitative-based decisions can transform and enhance the productivity and efficiency of the drug development process. With an aim to improve human health, we explore data, create models, and collaborate with our clients, colleagues, and the scientific community at large.
